122 related articles for article (PubMed ID: 22954251)
21. Rexinoids isolated from Sophora tonkinensis with a gene expression profile distinct from the synthetic rexinoid bexarotene.
Inoue M; Tanabe H; Nakashima K; Ishida Y; Kotani H
J Nat Prod; 2014 Jul; 77(7):1670-7. PubMed ID: 24959987
[TBL] [Abstract][Full Text] [Related]
22. Evaluating Novel RXR Agonists That Induce ApoE and Tyrosine Hydroxylase in Cultured Human Glioblastoma Cells.
Mallick S; Marshall PA; Wagner CE; Heck MC; Sabir ZL; Sabir MS; Dussik CM; Grozic A; Kaneko I; Jurutka PW
ACS Chem Neurosci; 2021 Mar; 12(5):857-871. PubMed ID: 33570383
[TBL] [Abstract][Full Text] [Related]
23. Retinoid X receptors: common heterodimerization partners with distinct functions.
Lefebvre P; Benomar Y; Staels B
Trends Endocrinol Metab; 2010 Nov; 21(11):676-83. PubMed ID: 20674387
[TBL] [Abstract][Full Text] [Related]
24. Retinoid X receptor-specific retinoids inhibit the ability of retinoic acid receptor-specific retinoids to increase the level of insulin-like growth factor binding protein-3 in human ectocervical epithelial cells.
Hembree JR; Agarwal C; Beard RL; Chandraratna RA; Eckert R
Cancer Res; 1996 Apr; 56(8):1794-9. PubMed ID: 8620495
[TBL] [Abstract][Full Text] [Related]
25. Alternative retinoid X receptor (RXR) ligands.
Krężel W; Rühl R; de Lera AR
Mol Cell Endocrinol; 2019 Jul; 491():110436. PubMed ID: 31026478
[TBL] [Abstract][Full Text] [Related]
26. [Retinoid signalling pathways].
Fukasawa H; Shudo K
Gan To Kagaku Ryoho; 1993 Apr; 20(5):555-66. PubMed ID: 8470912
[TBL] [Abstract][Full Text] [Related]
27. Growth factor-antagonized rexinoid apoptosis involves permissive PPARgamma/RXR heterodimers to activate the intrinsic death pathway by NO.
Shankaranarayanan P; Rossin A; Khanwalkar H; Alvarez S; Alvarez R; Jacobson A; Nebbioso A; de Lera AR; Altucci L; Gronemeyer H
Cancer Cell; 2009 Sep; 16(3):220-31. PubMed ID: 19732722
[TBL] [Abstract][Full Text] [Related]
28. Therapeutic potential of "rexinoids" in cancer prevention and treatment.
Tanaka T; De Luca LM
Cancer Res; 2009 Jun; 69(12):4945-7. PubMed ID: 19509234
[TBL] [Abstract][Full Text] [Related]
29. Role of retinoids and their cognate nuclear receptors in breast cancer chemoprevention.
Brtko J
Cent Eur J Public Health; 2007 Mar; 15(1):3-6. PubMed ID: 17491551
[TBL] [Abstract][Full Text] [Related]
30. The retinoid X receptor has a critical role in synthetic rexinoid-induced increase in cellular all-trans-retinoic acid.
Belyaeva OV; Klyuyeva AV; Vyas A; Berger WK; Halasz L; Yu J; Atigadda VR; Slay A; Goggans KR; Renfrow MB; Kane MA; Nagy L; Kedishvili NY
PLoS One; 2024; 19(4):e0301447. PubMed ID: 38557762
[TBL] [Abstract][Full Text] [Related]
31. Selective ligand activity at Nur/retinoid X receptor complexes revealed by dimer-specific bioluminescence resonance energy transfer-based sensors.
Giner XC; Cotnoir-White D; Mader S; Lévesque D
FASEB J; 2015 Oct; 29(10):4256-67. PubMed ID: 26148973
[TBL] [Abstract][Full Text] [Related]
32. Retinoids, rexinoids and their cognate nuclear receptors: character and their role in chemoprevention of selected malignant diseases.
Brtko J
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2007 Dec; 151(2):187-94. PubMed ID: 18345250
[TBL] [Abstract][Full Text] [Related]
33. Determinants of retinoid X receptor transcriptional antagonism.
Cavasotto CN; Liu G; James SY; Hobbs PD; Peterson VJ; Bhattacharya AA; Kolluri SK; Zhang XK; Leid M; Abagyan R; Liddington RC; Dawson MI
J Med Chem; 2004 Aug; 47(18):4360-72. PubMed ID: 15317450
[TBL] [Abstract][Full Text] [Related]
34. Aza-retinoids as novel retinoid X receptor-specific agonists.
Farmer LJ; Marron KS; Canan Koch SS; Hwang CK; Kallel EA; Zhi L; Nadzan AM; Robertson DW; Bennani YL
Bioorg Med Chem Lett; 2006 May; 16(9):2352-6. PubMed ID: 16364638
[TBL] [Abstract][Full Text] [Related]
35. A conserved retinoid X receptor (RXR) from the mollusk Biomphalaria glabrata transactivates transcription in the presence of retinoids.
Bouton D; Escriva H; de Mendonça RL; Glineur C; Bertin B; Noël C; Robinson-Rechavi M; de Groot A; Cornette J; Laudet V; Pierce RJ
J Mol Endocrinol; 2005 Apr; 34(2):567-82. PubMed ID: 15821117
[TBL] [Abstract][Full Text] [Related]
36. RXR: from partnership to leadership in metabolic regulations.
Desvergne B
Vitam Horm; 2007; 75():1-32. PubMed ID: 17368310
[TBL] [Abstract][Full Text] [Related]
37. Design and in vitro characterization of RXR variants as tools to investigate the biological role of endogenous rexinoids.
le Maire A; Rey M; Vivat V; Guée L; Blanc P; Malosse C; Chamot-Rooke J; Germain P; Bourguet W
J Mol Endocrinol; 2022 Oct; 69(3):377-390. PubMed ID: 35900852
[TBL] [Abstract][Full Text] [Related]
38. Therapeutic modulation of retinoid X receptors - SAR and therapeutic potential of RXR ligands and recent patents.
Schierle S; Merk D
Expert Opin Ther Pat; 2019 Aug; 29(8):605-621. PubMed ID: 31298602
[No Abstract] [Full Text] [Related]
39. A review of the molecular design and biological activities of RXR agonists.
de Almeida NR; Conda-Sheridan M
Med Res Rev; 2019 Jul; 39(4):1372-1397. PubMed ID: 30941786
[TBL] [Abstract][Full Text] [Related]
40. Modulators of the structural dynamics of the retinoid X receptor to reveal receptor function.
Nahoum V; Pérez E; Germain P; Rodríguez-Barrios F; Manzo F; Kammerer S; Lemaire G; Hirsch O; Royer CA; Gronemeyer H; de Lera AR; Bourguet W
Proc Natl Acad Sci U S A; 2007 Oct; 104(44):17323-8. PubMed ID: 17947383
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
